Med-tech firms raising money in public or private financings, including: Bellevue Life Sciences, Current Surgical.

New hires and promotions in the med-tech industry, including: Ellipsis Health, Think Surgical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ABVC, Akebia, Alnylam, Arcutis, Azafaros, Beckley, Biohaven, Biosyngen, Chemomab, Cincor, GC, Icosavax, Kadimastem, Mezzion, Optinose, Orasis, Pfizer, Regeneron, RVAC, Sinovac, Valneva, Vaxcyte.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axsome, Nanite, Pharmanovia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Aileron, Akari, Ascletis, BMS, Bridge, Effector, Gamida, Ionis, Junshi, Kinarus, Medivir, Merck & Co., Neurophth, Palvella, Pharming, Photocure, Scancell, Takeda, Telix, Westvac.

New hires and promotions in the biopharma industry, including: Cleara, Irlab, Phio, Radionetics, Vivtex.

Biopharmas raising money in public or private financings, including: Abilita, Apellis, Azitra, Biomx, Quoin, Sorrento.

The top 10 med-tech stock gainers and losers for the week.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Brim.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Accord, Athersys, Axcella, Biocon, Gracell, Healios, Henlius, Lemonex, Viatris.